ReWalk Robotics Ltd (LFWD) - Net Assets
Based on the latest financial reports, ReWalk Robotics Ltd (LFWD) has net assets worth $8.41 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($22.90 Million) and total liabilities ($14.49 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read total liabilities of ReWalk Robotics Ltd for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $8.41 Million |
| % of Total Assets | 36.72% |
| Annual Growth Rate | 0.2% |
| 5-Year Change | -87.67% |
| 10-Year Change | -61.39% |
| Growth Volatility | 151.79 |
ReWalk Robotics Ltd - Net Assets Trend (2016–2025)
This chart illustrates how ReWalk Robotics Ltd's net assets have evolved over time, based on quarterly financial data. Also explore how large is ReWalk Robotics Ltd's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for ReWalk Robotics Ltd (2016–2025)
The table below shows the annual net assets of ReWalk Robotics Ltd from 2016 to 2025. For live valuation and market cap data, see ReWalk Robotics Ltd (LFWD) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $8.41 Million | -55.39% |
| 2024-12-31 | $18.85 Million | -59.47% |
| 2023-12-31 | $46.51 Million | 0.00% |
| 2023-09-30 | $46.51 Million | -31.77% |
| 2022-12-31 | $68.17 Million | 0.00% |
| 2022-09-30 | $68.17 Million | -23.74% |
| 2021-12-31 | $89.38 Million | 0.00% |
| 2021-09-30 | $89.38 Million | +310.50% |
| 2020-12-31 | $21.77 Million | 0.00% |
| 2020-09-30 | $21.77 Million | +101.99% |
| 2019-12-31 | $10.78 Million | +454.24% |
| 2018-12-31 | $1.95 Million | -47.53% |
| 2017-12-31 | $3.71 Million | -55.12% |
| 2016-12-31 | $8.26 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to ReWalk Robotics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17824700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.21 Million | 73.92% |
| Other Components | $286.93 Million | 3412.61% |
| Total Equity | $8.41 Million | 100.00% |
ReWalk Robotics Ltd Competitors by Market Cap
The table below lists competitors of ReWalk Robotics Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Crest Builder Holdings Bhd
KLSE:8591
|
$25.06 Million |
|
Pantera Silver Corp
V:PNTR
|
$25.08 Million |
|
AJ Advance Technology Public Company Limited
BK:AJA
|
$25.08 Million |
|
Sephaku Holdings Ltd
JSE:SEP
|
$25.09 Million |
|
Brilliant Earth Group Inc
NASDAQ:BRLT
|
$25.05 Million |
|
Higgstec
TWO:5220
|
$25.05 Million |
|
ZK International Group Co Ltd
NASDAQ:ZKIN
|
$25.04 Million |
|
THE INX DIGITAL CO.INC.
F:FN4
|
$25.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in ReWalk Robotics Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 18,849,000 to 8,408,000, a change of -10,441,000 (-55.4%).
- Net loss of 19,914,000 reduced equity.
- New share issuances of 9,203,000 increased equity.
- Other factors increased equity by 270,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-19.91 Million | -236.85% |
| Share Issuances | $9.20 Million | +109.46% |
| Other Changes | $270.00K | +3.21% |
| Total Change | $- | -55.39% |
Book Value vs Market Value Analysis
This analysis compares ReWalk Robotics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 10.00x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.01x to 10.00x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $1316.81 | $7.25 | x |
| 2017-12-31 | $385.25 | $7.25 | x |
| 2018-12-31 | $111.00 | $7.25 | x |
| 2019-12-31 | $157.18 | $7.25 | x |
| 2020-12-31 | $116.06 | $7.25 | x |
| 2021-12-31 | $156.69 | $7.25 | x |
| 2022-12-31 | $91.83 | $7.25 | x |
| 2023-12-31 | $65.45 | $7.25 | x |
| 2024-12-31 | $26.04 | $7.25 | x |
| 2025-12-31 | $0.72 | $7.25 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently ReWalk Robotics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -236.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -90.38%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 2.72x
- Recent ROE (-236.85%) is above the historical average (-285.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -393.50% | -553.81% | 0.18x | 3.85x | $-33.33 Million |
| 2017 | -666.77% | -318.81% | 0.34x | 6.17x | $-25.09 Million |
| 2018 | -1114.40% | -331.17% | 0.44x | 7.69x | $-21.87 Million |
| 2019 | -144.26% | -319.13% | 0.20x | 2.26x | $-16.63 Million |
| 2020 | -59.59% | -295.38% | 0.16x | 1.29x | $-15.15 Million |
| 2021 | -14.25% | -213.48% | 0.06x | 1.06x | $-21.67 Million |
| 2022 | -28.71% | -355.09% | 0.07x | 1.09x | $-26.39 Million |
| 2023 | -47.59% | -159.76% | 0.22x | 1.36x | $-26.78 Million |
| 2024 | -153.55% | -112.78% | 0.84x | 1.62x | $-30.83 Million |
| 2025 | -236.85% | -90.38% | 0.96x | 2.72x | $-20.75 Million |
Industry Comparison
This section compares ReWalk Robotics Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $2,432,799,891
- Average return on equity (ROE) among peers: -74.29%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| ReWalk Robotics Ltd (LFWD) | $8.41 Million | -393.50% | 1.72x | $25.05 Million |
| Abbott Laboratories (ABT) | $24.16 Billion | 9.46% | 0.81x | $155.56 Billion |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $21.60 Million |
| Aethlon Medical Inc (AEMD) | $9.29 Million | -84.45% | 0.15x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $105.73 Million | -116.68% | 0.61x | $903.35K |
| Adapthealth Corp (AHCO) | $15.14 Million | -140.98% | 14.05x | $1.39 Billion |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $2.15 Million | -112.84% | 0.45x | $16.04 Million |
| Allurion Technologies, Inc. (ALUR) | $-70.49 Million | 0.00% | 0.00x | $8.60 Million |
| Autonomix Medical, Inc. Common Stock (AMIX) | $644.00K | -309.01% | 0.34x | $4.22 Million |
| Artivion Inc (AORT) | $89.39 Million | 8.74% | 0.25x | $1.73 Billion |
| Apyx Medical Inc (APYX) | $21.15 Million | 2.82% | 0.30x | $125.55 Million |
About ReWalk Robotics Ltd
Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal… Read more